PhD Scientist, Norway.
Session: Delivery of lipid nanoparticles with RNA, how does it work?
Kjetil Elvevold holds a PhD in liver physiology and is a former researcher in the pharmaceutical industry. He has led research on lipid nanoparticles with mRNA.
Elvevold has questioned whether the basis for emergency approval of the vaccine was well-documented enough and has faced strong criticism in recent years.
After Elvevold’s lecture, you will have a better understanding of how mRNA works and gain insight into how this can affect the human body and why the vaccine cannot be called a vaccine.